|
|
Best of IBD Summit: Case-based Management Strategies, Patient Perspectives, and Hot Topics
Inflammatory bowel disease (IBD), of which Crohn’s disease and ulcerative colitis are the main subtypes, is a chronic relapsing condition characterized by an overly active immune response in the gut, resulting in bowel inflammation and ulceration. Given the increasing prevalence of disease and influx of available biologics and small molecule therapies, gastroenterology fellows can benefit from ongoing education regarding the diagnosis, classification, and evidence-based management of patient... |
|
|
Best of IBD Summit: Navigating Loss of Response, Maintenance Therapy, and Fistulizing CD
Inflammatory bowel disease (IBD), of which Crohn’s disease and ulcerative colitis are the main subtypes, is a chronic relapsing condition characterized by an overly active immune response in the gut, resulting in bowel inflammation and ulceration. Given the increasing prevalence of disease and influx of available biologics and small molecule therapies, gastroenterology fellows can benefit from ongoing education regarding the diagnosis, classification, and evidence-based management of patient... |
|
|
Best of IBD Summit: Case-based Management Strategies, Patient Perspectives, and Hot Topics
Inflammatory bowel disease (IBD), of which Crohn’s disease and ulcerative colitis are the main subtypes, is a chronic relapsing condition characterized by an overly active immune response in the gut, resulting in bowel inflammation and ulceration. Given the increasing prevalence of disease and influx of available biologics and small molecule therapies, gastroenterology fellows can benefit from ongoing education regarding the diagnosis, classification, and evidence-based management of patient... |
|
|
Best of IBD Summit: Navigating Loss of Response, Maintenance Therapy, and Fistulizing CD
Inflammatory bowel disease (IBD), of which Crohn’s disease and ulcerative colitis are the main subtypes, is a chronic relapsing condition characterized by an overly active immune response in the gut, resulting in bowel inflammation and ulceration. Given the increasing prevalence of disease and influx of available biologics and small molecule therapies, gastroenterology fellows can benefit from ongoing education regarding the diagnosis, classification, and evidence-based management of patient... |
|
|
Optimizing Transition from Pediatric to Adult Care - LIVE STREAMING
In this special program, faculty from Harvard Medical School, the Brigham Transition Care Team, and the Boston Children’s Hospital BRIDGES Adult Transition Program provide strategies, best practices, and guidance to:
• Identify adult care providers and successfully transfer patients with rare or complex health care needs
• Assess and improve the efficacy of your current transition processes
• Tailor transition strategies to patient age, disease type, and physical/ intellectual capab... |
|
|
Answers to the Questions You May Not be Asking: Treating Ulcerative Colitis Considerate of Patient-Centric Factors
Are you aware of the latest evidence-based strategies in ulcerative colitis (UC)? Looking to expand your ability to incorporate patient-centric factors into selection of therapy for UC? Navigate through this novel, interactive self-directed activity designed to optimize your decision making in selection of therapy for UC. View expert perspectives and insights who can help you apply newer strategies such as treat-to-target (T2T) and therapeutic drug monitoring (TDM) for the treatment for your ... |
|